Golden Belt Home Health And Hospice Location: 3515 Broadway, Suite 214, Great Bend, Kansas 67530 Ratings: Phone: (620) 792-8171 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).
Scientists at Johns Hopkins have linked a stem-cell gene to a portion of one of the most common childhood brain cancers, opening the door to tailored therapies that block the gene's tumor-promoting ability.
"In mid-July, ... the near-final draft of the independent evaluation of the Affordable Medicines Facility - Malaria (AMFm) was released," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Heather Lanthorn, a doctoral candidate at Harvard School of Public Health, write in this post in the center's "Global Health Policy" blog.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"We were deeply perturbed to learn that the negotiations for the Outcomes Document of the U.N. High Level Meeting on Non-Communicable Diseases (NCDs), a mere month or so away, had stalled because member states failed to reach consensus," Nalini Saligram, CEO of Arogya World, and Sandeep Kishore, an MD/PhD candidate at the Cornell/ Rockefeller/ Sloan-Kettering Institute, write in a Huffington Post opinion piece.
› Verified 1 days ago